Advisor Group Holdings, Inc. Idera Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.41 - $0.7 $24 - $41	-59 Reduced 66.29%	30 $0
Q2 2021 Aug 02, 2021	SELL	$1.01 - $1.58 $704 - $1,102	-698 Reduced 88.69%	89 $0
Q4 2020 Feb 10, 2021	SELL	$2.09 - $5.18 $261 - $647	-125 Reduced 13.71%	787 $3,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.68 $51 - $80	30 Added 3.4%	912 $2,000
Q2 2020 Aug 14, 2020	BUY	$1.23 - $2.12 $858 - $1,479	698 Added 379.35%	882 $1,000

Q1 2020 May 18, 2020	BUY	$1.06 - $2.15 $195 - $395	184 New	184 $0

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.